Atlas Trials

Clinical Study of Meplazumab to Treat With Malaria

Clinical trial NCT04327310 · WITHDRAWN

Trial details

NCT number
NCT04327310
Sponsor
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Malaria (Plasmodium Falciparum)
Start date
2023-03-01
Primary completion
2023-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.